No Result
View All Result
Global Finances Daily
  • Alternative Investments
  • Crypto
  • Financial Markets
  • Investments
  • Lifestyle
  • Protection
  • Retirement
  • Savings
  • Work & Careers
No Result
View All Result
  • Alternative Investments
  • Crypto
  • Financial Markets
  • Investments
  • Lifestyle
  • Protection
  • Retirement
  • Savings
  • Work & Careers
  • Login
Global Finances Daily
No Result
View All Result
Home Savings

Stocks making the biggest moves premarket: KSS, CASY, VRTX

March 10, 2026
in Savings
0
Stocks making the biggest moves premarket: KSS, CASY, VRTX


Check out the companies making headlines before the bell: Kohl’s — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.07 per share exceeded the expected 85 cents per share. Casey’s General Stores — The convenience store chain shed 2.6% following its third-quarter revenue miss. Casey’s General Stores reported revenue of $3.92 billion, short of the $4.04 billion consensus estimate, per FactSet. Earnings, however, topped expectations. Taiwan Semiconductor — The Taiwanese chipmaker’s shares inched up about 1% in premarket after the company reported a 30% increase in sales over the first two months of the year. Vail Resorts — The ski resort’s stock price slid 1.1% after reporting earnings of $5.87 per share on $1.08 billion in revenue, while analysts polled by LSEG expected $6.10 per share on $1.11 billion in revenue. The company also lowered its guidance “due to the persistent, historically challenging weather conditions in the Rockies.” Hewlett Packard Enterprise — Shares of the technology company rose 1%. HPE earned 65 cents per share, on an adjusted basis, for its first quarter. That exceeded analysts’ estimate of 59 cents per share, according to LSEG. The company’s $9.30 billion in revenue fell slightly short of the $9.33 billion expected, meanwhile. Vertex Pharmaceuticals — Vertex Pharmaceuticals shares advanced more than 6% after the biotech company said its drug met its goals in a late-stage trial for IgA nephropathy, a chronic condition that can lead to kidney failure. — CNBC’s Michelle Fox, Yun Li and Pia Singh contributed reporting

Editorial Team

Editorial Team

Related Posts

7 software stocks to buy as the sector shows signs of life
Savings

7 software stocks to buy as the sector shows signs of life

March 10, 2026
Stocks making the biggest moves midday: RIVN, HIMS, BNTX, VRTX
Savings

Stocks making the biggest moves midday: RIVN, HIMS, BNTX, VRTX

March 10, 2026
Nvidia investors banking on a big GTC stock bump may be disappointed
Savings

Nvidia investors banking on a big GTC stock bump may be disappointed

March 10, 2026
Saudi Aramco chief warns of catastrophic consequence of Hormuz shutdown even as oil giant works on end-around
Savings

Saudi Aramco chief warns of catastrophic consequence of Hormuz shutdown even as oil giant works on end-around

March 10, 2026
Iran war disrupts oil prices; consumers may be 'hammered': economist
Savings

Iran war disrupts oil prices; consumers may be ‘hammered’: economist

March 10, 2026
Bill Ackman tries again with plan for IPO of Pershing Square and a new fund
Savings

Bill Ackman tries again with plan for IPO of Pershing Square and a new fund

March 10, 2026
Load More
Next Post
Compare Bitcoin mining features, fees, and performance

While markets react to global conflict, BI DeFi users are still earning

Popular News

  • Airport, Airfield, Aircraft

    Why My New Favorite American Airlines Card Is the Citi Strata Elite

    0 shares
    Share 0 Tweet 0
  • Rothschild & Co’s advisory unit launches new capital markets brand

    0 shares
    Share 0 Tweet 0
  • How to Contact Hilton Customer Service

    0 shares
    Share 0 Tweet 0
  • Michael Saylor sets daily record with 1,360 Bitcoin buy

    0 shares
    Share 0 Tweet 0
  • Bitcoin Long-Term Holder Rate Returns To 2021 Levels, Good News For Crypto?

    0 shares
    Share 0 Tweet 0

Latest News

Exploring the Peruvian Amazon, One Riverbend at a Time, on Abercrombie & Kent’s Debut Voyage

Exploring the Peruvian Amazon, One Riverbend at a Time, on Abercrombie & Kent’s Debut Voyage

March 10, 2026
0

A chorus of high-pitched squeals cuts through the blanket of mist. We steer our skiff, bobbing up and down on...

The governance problem Bitcoin has never solved

Court‑ordered BTC return to Bitfinex sets a precedent for crypto victim rights

March 10, 2026
0

Bitfinex is about to get a massive chunk of its past back as a U.S. court orders more than 94,000...

Meta Is Buying Moltbook | Lifehacker

Meta Is Buying Moltbook | Lifehacker

March 10, 2026
0

Meta, the company behind platforms like Facebook, Instagram, and WhatsApp, is now acquiring a new social media platform. Unlike its...

Nvidia targets enterprise AI agents with new open-source NemoClaw platform

Nvidia targets enterprise AI agents with new open-source NemoClaw platform

March 10, 2026
0

Nvidia is preparing to launch an open-source AI agent platform called NemoClaw, according to a WIRED report, as the chipmaker...

Global Finances Daily

Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.

Subscribe

  • About Us
  • Contact
  • Privacy Policy
  • Terms of Use
  • Editorial Process

© 2025 All Rights Reserved - Global Finances Daily.

No Result
View All Result
  • Alternative Investments
  • Crypto
  • Financial Markets
  • Investments
  • Lifestyle
  • Protection
  • Retirement
  • Savings
  • Work & Careers

© 2025 All Rights Reserved - Global Finances Daily.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.